A multivalent Plasmodium falciparum circumsporozoite protein‐based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats

Plasmodium falciparum (Pf) malaria continues to cause considerable morbidity and mortality worldwide. The circumsporozoite protein (CSP) is a particularly attractive candidate for designing vaccines that target sporozoites—the first vertebrate stage in a malaria infection. Current PfCSP‐based vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pendyala, Geetanjali, Calvo‐Calle, J. Mauricio, Moreno, Alberto, Kane, Ravi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354751/
https://www.ncbi.nlm.nih.gov/pubmed/37476056
http://dx.doi.org/10.1002/btm2.10514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354751/
https://www.ncbi.nlm.nih.gov/pubmed/37476056
http://dx.doi.org/10.1002/btm2.10514

Ejemplares similares